Basic information Safety Supplier Related

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one

Basic information Safety Supplier Related

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one Basic information

Product Name:
7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one
Synonyms:
  • BUTTPARK 120\07-73
  • -broMo-2H-benzo[b][1,4]oxazin-3(4H)-one
  • 7-broMo-3,4-dihydro-2H-1,4-benzoxazin-3-one
  • 7-BROMO-2H-1,4-BENZOXAZIN-3(4H)-ONE
  • 7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one
  • BUTTPARK 120
  • 7-BroMo-4H-benzo[1,4]oxazin-3-one
  • 7-Bromo-4H-1,4-benzoxazin-3-one
CAS:
321436-06-0
MF:
C8H6BrNO2
MW:
228.04
EINECS:
200-589-5
Mol File:
321436-06-0.mol
More
Less

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one Chemical Properties

Boiling point:
381.5±42.0 °C(Predicted)
Density 
1.676
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
pka
11.76±0.20(Predicted)
Appearance
Light brown to brown Solid
InChI
InChI=1S/C8H6BrNO2/c9-5-1-2-6-7(3-5)12-4-8(11)10-6/h1-3H,4H2,(H,10,11)
InChIKey
ZAXUQDMKVBOVCR-UHFFFAOYSA-N
SMILES
O1C2=CC(Br)=CC=C2NC(=O)C1
More
Less

Safety Information

HS Code 
2934999090
More
Less

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one Usage And Synthesis

Uses

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-one is used in the pharmaceutical field as an anticancer agent component, and in organic synthesis as a synthetic reaction reagent or intermediate component.

Synthesis

38191-34-3

79-04-9

321436-06-0

2. 2-Amino-5-bromophenol (2.53 g, 18.2 mmol, 1.0 eq.) was dissolved in a solvent mixture of 15 mL of isobutylmethyl ketone and 15 mL of water, and cooled to 0 °C. Subsequently, NaHCO3 (3.67 g, 2.4 eq.) and chloroacetyl chloride (2.36 g, 1.67 mL, 1.15 eq.) were added. The reaction mixture was heated to reflux and stirred overnight, then cooled to room temperature. After completion of the reaction, the mixture was diluted with ethyl acetate, washed sequentially with water, dried with MgSO4 and finally concentrated under vacuum. Purification by silica gel column chromatography afforded 7-bromo-3,4-dihydro-2H-1,4-benzoxazin-3-one in 77% yield. After analyzed by low resolution mass spectrometry (LRMS), the molecular ion peak (M + H)+ was measured to be 180.1, which was consistent with the theoretical value of C9H10NO3.

References

[1] Journal of Medicinal Chemistry, 2015, vol. 58, # 1, p. 222 - 236
[2] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 5, p. 592 - 597
[3] MedChemComm, 2015, vol. 6, # 7, p. 1375 - 1380
[4] ChemMedChem, 2015, vol. 10, # 11, p. 1821 - 1836
[5] Patent: US6534535, 2003, B1

7-Bromo-2H-benzo[b][1,4]oxazin-3(4H)-oneSupplier

Shanghai Kahn Pharmaceutical Co., Ltd. Gold
Tel
021-34979681; 17701870669
Email
41513101@qq.com
Niuruisi Medical Technology Co. Ltd. Gold
Tel
13872091715
Email
cheng1297@126.com
TR Pharma & Tech Co., Ltd. Gold
Tel
0531-88633905 15863156350
Email
jntryy@hotmail.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com